quinone methide has been researched along with Astrocytoma, Grade IV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cross, D; Engel, M; Gee, YS; Guillemin, GJ; Heng, B; Hulme, A; Hyland, CJT; Maccarone, A; Ooi, L; Smith, G; Stringer, BW | 1 |
1 other study(ies) available for quinone methide and Astrocytoma, Grade IV
Article | Year |
---|---|
Novel dual-action prodrug triggers apoptosis in glioblastoma cells by releasing a glutathione quencher and lysine-specific histone demethylase 1A inhibitor.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cells, Cultured; Cyclopropanes; Drug Design; Glioblastoma; Glutathione; Histone Demethylases; Humans; Indolequinones; Prodrugs | 2019 |